Search images on Google      Product Monograph

Active Ingredients:

• insulin glargine, 100 UNIT/ML

DIN: 02444844

Dosage Form(s): SOLUTION

Route(s) of Administration: SUBCUTANEOUS

Description: CARTRIDGE

Schedule: Schedule D

Company: ELI LILLY CANADA INC  –  official site

ATC:

• A10 - DRUGS USED IN DIABETES (ATC, WHO, Wiki)
• A10A - INSULINS AND ANALOGUES (ATC, WHO)
• A10AE - Insulins and analogues for injection, long-acting (ATC, WHO)
• A10AE04 - INSULIN GLARGINE (WHO)

Reference brand drug: Lantus

Pharmaceutical standard: USP

 

External Links for Basaglar:

Search on Google

• Basaglar side effects
• Basaglar dosage
• insulin glargine side effects
• insulin glargine dosage

Eli Lilly Canada Inc

Go to Eli Lilly website to see drug product details. Sometimes you can find basaglar photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.